INNOVATION
12 Dec 2025
TECHNOLOGY
10 Dec 2025
INSIGHTS
24 Nov 2025
INNOVATION
19 Nov 2025

INVESTMENT
17 Nov 2025
AstraZeneca and Algen team up on gene editing and AI to tackle immune diseases

INNOVATION
24 Jun 2025
Editas’ single-dose CRISPR therapy could make sickle cell treatment faster, cheaper, and far more accessible.

REGULATORY
17 Jun 2025
FDA speeds cell and gene therapy reviews, aiming for faster access without lowering safety standards.

INNOVATION
5 Jun 2025
Sector turns to next-generation delivery and risk controls as in vivo gene editing moves toward wider clinical use

PARTNERSHIPS
21 May 2025
CHOP, Penn, and Acuitas use lipid nanoparticles for rare genetic disorder, bypassing viral vectors for the first time in the US.

INSIGHTS
15 May 2025
Mammoth’s one-dose CRISPR delivery to muscle raises hopes for wider, safer genetic treatments.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.